French Electrical Stock News

A consortium of market infrastructure and trading firms recently completed a third wave of transactions on the Canton Network, using tokenized commercial bank deposits via LSEG Digital Settlement House and tokenized collateral such as European government bonds and U.S. Treasuries for on-chain intraday repo across multiple currencies and borders. Euronext highlighted that this work is part of a broader industry push to build tokenization and on-chain infrastructure while staying aligned with...

If you are wondering whether ABIVAX Société Anonyme is priced attractively right now, it helps to separate the recent excitement from what the numbers actually say about value. The share price last closed at €103.60, with returns of 4.4% over 7 days, 10.1% over 30 days and a very large gain over the past year, although year to date the stock shows a 9.9% decline. These moves have come as ABIVAX Société Anonyme continues to attract attention in the French pharmaceuticals and biotech space,...

Media reports around Eurazeo (ENXTPA:RF) potentially exiting its investment in French beauty retailer Aroma-Zone, after several years of store expansion, have put fresh attention on how this holding fits into the group’s portfolio. See our latest analysis for Eurazeo. The Aroma-Zone headlines arrive as Eurazeo’s share price has edged higher in the very short term, with a 1-day share price return of 1.14% and 7-day share price return of 3.00%. This sits against a 90-day share price return...

In early January 2026, reports indicated that EssilorLuxottica and Meta Platforms were considering significantly increasing production capacity for their AI-powered Ray-Ban smart glasses to meet strong demand. This potential scale-up in smart glasses output highlights EssilorLuxottica’s push deeper into technology-enabled eyewear, expanding beyond traditional lenses and frames into AI wearables. We’ll now examine how this potential ramp-up in AI-powered smart glasses production could...

Eramet (ENXTPA:ERA) has become a talking point after reporting A minus scores for both Climate Change and Water Security in the 2025 Carbon Disclosure Project cycle, reinforcing attention on its “Act for Positive Mining” roadmap. See our latest analysis for ERAMET. The €85.2 share price has been moving sharply, with a 24.65% 7 day share price return and a 79.37% 30 day share price return feeding into a 58.09% 1 year total shareholder return. This suggests momentum has recently picked up as...

Legrand SA ( EPA:LR ) received a lot of attention from a substantial price movement on the ENXTPA over the last few...

Unfortunately for some shareholders, the Vusion S.A. ( EPA:VU ) share price has dived 27% in the last thirty days...

These days it's easy to simply buy an index fund, and your returns should (roughly) match the market. But if you pick...

Wondering if BNP Paribas at €87.38 is offering good value or if the easy money has already been made? This article breaks down what the current price might really imply. The stock has seen returns of 5.9% over the last 7 days, 10.8% over the last 30 days and 54.6% over the last year, with longer term returns of 86.4% over 3 years and 178.8% over 5 years. These moves have played out alongside ongoing investor focus on large European banks and how their balance sheets, capital positions and...

In early January 2026, Pluxee N.V. reported fiscal first-quarter revenue of €308 million, up from €289 million a year earlier, and separately disclosed recent treasury share repurchase transactions. The combination of higher year-on-year revenue and continued buybacks highlights management’s focus on both growing the business and actively managing the capital structure. We’ll now examine how Pluxee’s first-quarter revenue growth shapes its investment narrative built around expansion,...

Why the new drone contracts matter for Exail shareholders Exail Technologies (ENXTPA:EXA) has just secured fresh contracts across its DriX H-9 surface drones and K-STER mine neutralization systems, putting the spotlight on how its autonomous maritime portfolio might influence the stock. See our latest analysis for Exail Technologies. The fresh DriX H-9 and K-STER contracts arrive after a strong run in the shares, with a 30-day share price return of 22.95% and a year to date share price return...

In early January 2026, Voltalia SA updated its outlook, indicating that the net loss attributable to the Group in the second half of 2025 was higher than in the first half. This guidance signals that, despite longer-term ambitions, the company faced increasing near-term pressures on profitability heading into the end of 2025. We’ll now explore how the expectation of a higher second-half 2025 net loss could influence Voltalia’s existing investment narrative. These 14 companies survived and...

As European markets start the year with optimism, the pan-European STOXX Europe 600 Index has risen by 2.27%, buoyed by positive economic signals and a favorable interest rate environment. In this context, penny stocks—often seen as relics of past market eras—continue to offer intriguing opportunities for investors seeking growth potential in smaller or newer companies. While traditionally associated with higher risk, these stocks can present compelling value when underpinned by strong...

Key Insights Cellectis' significant individual investors ownership suggests that the key decisions are influenced by...

Valeo SE ( EPA:FR ), might not be a large cap stock, but it received a lot of attention from a substantial price...

As 2026 begins, the European stock market is buoyant with optimism, as evidenced by a 2.27% rise in the STOXX Europe 600 Index, driven by strengthening economies and favorable interest rate conditions across the eurozone. In this environment of economic revival and positive sentiment, identifying stocks that exhibit strong fundamentals and growth potential becomes crucial for investors seeking opportunities in Europe's small-cap sector.

SCOR (EPA:SCR) has had a rough three months with its share price down 7.0%. But if you pay close attention, you might...

Airbus (ENXTPA:AIR) is back in focus after reporting 793 commercial aircraft deliveries for 2025, along with 1,000 new orders and a record backlog of 8,754 jets, including 1,124 widebodies. See our latest analysis for Airbus. The latest aircraft delivery beat and record backlog sit against a mixed price picture, with a recent 9.86% 1 month share price return but a 2.16% 1 day pullback as investors digest new alliances in quantum computing and fuel cell technology. Overall, Airbus combines...

If you are wondering whether TotalEnergies at around €57.06 is offering fair value or a potential mispricing, you are in the right place for a clear look at what the current market price might be saying. The share price has recent returns of 6.6% over 7 days, 2.8% over 30 days, 1.7% year to date, 8.4% over 1 year and 12.7% over 3 years, with a very large 5 year return that suggests long term holders have seen strong compounding. Recent coverage around large integrated energy companies has...

In recent days, L'Oréal S.A. completed a series of euro-denominated bond issues totaling €1.75 billion, including floating-rate notes due 2028 and fixed-rate bonds maturing between 2029 and 2032, to help fund its planned additional 10% stake in Galderma and other corporate purposes. At the same time, L’Oréal’s partnership with iSMART Developments on flexible LED masks and its CES 2026 award-winning beauty tech devices highlight how the group is extending beyond traditional cosmetics into...

As the European markets continue to show optimism with major stock indexes rising, investors are keenly observing opportunities across various sectors. Penny stocks, often seen as a relic of past market eras, still hold potential for growth by offering affordability and the promise of future gains when supported by strong financials. In this article, we spotlight three European penny stocks that exemplify this potential through their robust balance sheets and promising prospects.

Leerink Partners recently initiated coverage on Inventiva with an Outperform rating and a US$12.00 price target, following earlier positive views from UBS and Wolfe Research on the company’s lead NASH/MASH candidate lanifibranor. At the same time, Inventiva secured about US$172.5 million in planned equity financing alongside a US$150 million ADS offering, reinforcing funding for the fully enrolled Phase 3 NATiV3 trial in a disease area that still has no approved therapies. We’ll now examine...

As European markets continue to show optimism, with the STOXX Europe 600 Index rising by 2.27% amid a favorable economic backdrop and positive company earnings, investors are exploring various opportunities across the continent. Penny stocks, while often considered a niche area of investment, still offer potential for growth, particularly when these smaller or newer companies demonstrate strong financial health. In this article, we will explore three penny stocks that may combine balance...

Key Insights Significant control over Métropole Télévision by private companies implies that the general public has...